We are live on ! Find out more
EAM

Eventide Asset Management Portfolio holdings

AUM $6.05B
1-Year Est. Return 76.64%
This Fund
S&P 500
This Quarter Est. Return
+13.86%
1 Year Est. Return
+76.64%
3 Year Est. Return
+247.17%
5 Year Est. Return
+285.6%
10 Year Est. Return
+2,546.71%
AUM
$2.41B
AUM Growth
+$274M
Cap. Flow
+$112M
Cap. Flow %
4.66%
Top 10 Hldgs %
24.57%
Holding
158
New
13
Increased
40
Reduced
8
Closed
14

Top Buys

Rank Stock Value
1
DNTH icon
Dianthus Therapeutics
DNTH
+$31.6M
2
TECX
Tectonic Therapeutic
TECX
+$27.9M
3
MYOV
Myovant Sciences Ltd.
MYOV
+$22.5M
4
PANW icon
Palo Alto Networks
PANW
+$20.8M
5
SAGE
Sage Therapeutics
SAGE
+$18.8M

Top Sells

Rank Stock Value
1
AVXS
AveXis, Inc. Common Stock
AVXS
+$52M
2
CAFD
8point3 Energy Partners LP
CAFD
+$18.9M
3
ONCE
Spark Therapeutics, Inc. Common Stock
ONCE
+$18M
4
TWLO icon
Twilio
TWLO
+$12.5M
5
SNA icon
Snap-on
SNA
+$10.6M

Sector Composition

Rank Sector Weight
1 Healthcare 42.26%
2 Technology 16.99%
3 Consumer Discretionary 12.15%
4 Industrials 8.07%
5 Utilities 2.6%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
DBVT
101
DBV Technologies
DBVT
$817M
$3.28M 0.14%
17,000
– –
DERM
102
DELISTED
Dermira, Inc.
DERM
$3.07M 0.13%
334,000
– –
BEP icon
103
Brookfield Renewable
BEP
$9.9B
$3.06M 0.13%
191,403
+5,629
+3% +$92.1K
MGNX icon
104
MacroGenics
MGNX
$240M
$3.04M 0.13%
147,000
– –
GYRE icon
105
Gyre Therapeutics
GYRE
$648M
$2.87M 0.12%
+32,800
New +$5.75M
FHB icon
106
First Hawaiian
FHB
$3.4B
$2.68M 0.11%
92,500
+4,000
+5% +$115K
ABB
107
DELISTED
ABB Ltd
ABB
$2.41M 0.1%
110,500
+15,500
+16% +$360K
DLPH
108
DELISTED
Delphi Technologies PLC Ordinary Shares
DLPH
$2.39M 0.1%
52,666
– –
PTCT icon
109
PTC Therapeutics
PTCT
$6.26B
$2.3M 0.1%
68,200
– –
JCI icon
110
Johnson Controls International
JCI
$87.8B
$2.26M 0.09%
67,500
+1,000
+2% +$34.7K
HMC icon
111
Honda
HMC
$39.9B
$2.23M 0.09%
76,000
+17,000
+29% +$559K
TSM icon
112
TSMC
TSM
$2.09T
$2.17M 0.09%
59,500
+18,000
+43% +$711K
SEP
113
DELISTED
Spectra Engy Parters Lp
SEP
$2.13M 0.09%
60,000
+5,000
+9% +$163K
BDN
114
Brandywine Realty Trust
BDN
$525M
$1.93M 0.08%
114,500
+11,000
+11% +$176K
BG icon
115
Bunge Global
BG
$20.4B
$1.92M 0.08%
27,500
+5,800
+27% +$415K
ETN icon
116
Eaton
ETN
$150B
$1.83M 0.08%
24,500
+7,500
+44% +$580K
EPIX
117
DELISTED
ESSA Pharma
EPIX
$1.82M 0.08%
481,971
– –
ACAD icon
118
Acadia Pharmaceuticals
ACAD
$4.55B
$1.74M 0.07%
113,600
– –
SYRS
119
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$1.53M 0.06%
15,000
– –
GPMT
120
Granite Point Mortgage Trust
GPMT
$64.7M
$1.5M 0.06%
82,000
+26,500
+48% +$468K
MLKN icon
121
MillerKnoll
MLKN
$1.53B
$1.49M 0.06%
44,000
+3,200
+8% +$106K
TERP
122
DELISTED
TerraForm Power, Inc
TERP
$1.45M 0.06%
123,500
-37,500
-23% -$419K
CCI.PRA
123
DELISTED
Crown Castle International Corp. 6.875% Mandatory Convertible Preferred Stock, Series A
CCI.PRA
$1.44M 0.06%
1,355
+365
+37% +$386K
APU
124
DELISTED
AmeriGas Partners, L.P.
APU
$1.35M 0.06%
32,000
– –
CVA
125
DELISTED
Covanta Holding Corporation
CVA
$1.29M 0.05%
78,500
+5,000
+7% +$78.7K
3 4
5
6 7

Similar funds

HPG
Harvest Portfolios Group Oakville, Ontario, Canada $6.06B AUM 16.63% 1-Year Est. Return
EMPI
Elo Mutual Pension Insurance Espoo, Finland $6.06B AUM 24.33% 1-Year Est. Return
RCG
Ruane, Cunniff & Goldfarb New York $6.03B AUM 12.06% 1-Year Est. Return
JWBC
John W. Bristol & Co New York $6.08B AUM 16.51% 1-Year Est. Return
AAM
Advisors Asset Management Monument, Colorado $6.01B AUM 24.74% 1-Year Est. Return
AA
AQR Arbitrage Greenwich, Connecticut $6.09B AUM 27.01% 1-Year Est. Return
CM
CastleKnight Management New York $6B AUM 121.87% 1-Year Est. Return
CIS
Capital International Sarl Los Angeles, California $6.11B AUM 32.29% 1-Year Est. Return

Eventide Asset Management's Q2 2018 Portfolio in Review

As of Q2 2018, Eventide Asset Management held 158 positions worth $2.41B, up 13% from $2.14B the previous quarter. Its ten largest holdings account for 25% of the portfolio.

Eventide Asset Management deployed $112M of net new capital in Q2 2018, opening 13 new positions and adding to 40 existing holdings. Its largest new stake was Dianthus Therapeutics: 139,881 shares worth $29.5M.

By sector, the portfolio is most concentrated in Healthcare at 42% of assets, up from 38% a quarter earlier, followed by Technology and Consumer Discretionary.

On the sell side, the largest reduction was Snap-on, an estimated $10.6M trimmed.

  • Eventide Asset Management's largest Q2 2018 buy was Dianthus Therapeutics: 139,881 shares worth $29.5M.
  • Eventide Asset Management added most to Myovant Sciences Ltd. in Q2 2018, an estimated $22.5M increase.
  • Eventide Asset Management's biggest Q2 2018 reduction was Snap-on, cutting an estimated $10.6M.
  • Eventide Asset Management fully exited AveXis, Inc. Common Stock in Q2 2018, selling an estimated $52M.
  • Eventide Asset Management's ten largest holdings make up 25% of its $2.41B portfolio in Q2 2018.
  • Eventide Asset Management opened 13 new positions and closed 14 in Q2 2018.
  • Eventide Asset Management's portfolio value rose 13% quarter-over-quarter to $2.41B.

Based on Eventide Asset Management's 13F filing for Q2 2018, filed 14 Aug 2018.